{"id":"https://openalex.org/W7224912043","doi":"https://doi.org/10.1097/iae.0000000000005045","title":"READING SPEED IN MACULAR TELANGIECTASIA TYPE 2: AN ANALYSIS OF SHAM PATIENTS IN THE REVAKINAGENE TARORETCEL-LWEY (NT-501) PHASE 3 TRIALS","display_name":"READING SPEED IN MACULAR TELANGIECTASIA TYPE 2: AN ANALYSIS OF SHAM PATIENTS IN THE REVAKINAGENE TARORETCEL-LWEY (NT-501) PHASE 3 TRIALS","publication_year":2026,"publication_date":"2026-10-30","ids":{"openalex":"https://openalex.org/W7224912043","doi":"https://doi.org/10.1097/iae.0000000000005045","pmid":"https://pubmed.ncbi.nlm.nih.gov/42961160"},"language":"en","primary_location":{"id":"doi:10.1097/iae.0000000000005045","doi":"https://doi.org/10.1097/iae.0000000000005045","is_oa":true,"landing_page_url":"https://doi.org/10.1097/iae.0000000000005045","pdf_url":null,"source":{"id":"https://openalex.org/S19572933","display_name":"Retina","issn_l":"0275-004X","issn":["0275-004X","1539-2864"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/iae.0000000000005045","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038698286","display_name":"Dean Eliott","orcid":"https://orcid.org/0000-0002-7699-1053","observed_orcids":["https://orcid.org/0000-0002-7699-1053"]},"institutions":[{"id":"https://openalex.org/I1287163989","display_name":"Massachusetts Eye and Ear Infirmary","ror":"https://ror.org/04g3dn724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1287163989"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dean Eliott","raw_affiliation_strings":["Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts;","institution_ids":["https://openalex.org/I1287163989","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5098661633","display_name":"Kensington A. Hatcher","orcid":"https://orcid.org/0009-0009-0657-7162","observed_orcids":["https://orcid.org/0009-0009-0657-7162"]},"institutions":[{"id":"https://openalex.org/I4210089059","display_name":"Neurotech (United States)","ror":"https://ror.org/0083rgp58","country_code":"US","type":"company","lineage":["https://openalex.org/I4210089059"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kensington A. Hatcher","raw_affiliation_strings":["Neurotech Pharmaceuticals, Cumberland, Rhode Island;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurotech Pharmaceuticals, Cumberland, Rhode Island;","institution_ids":["https://openalex.org/I4210089059"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053705654","display_name":"Michael J. DelGiodice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089059","display_name":"Neurotech (United States)","ror":"https://ror.org/0083rgp58","country_code":"US","type":"company","lineage":["https://openalex.org/I4210089059"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Delgiodice","raw_affiliation_strings":["Neurotech Pharmaceuticals, Cumberland, Rhode Island;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurotech Pharmaceuticals, Cumberland, Rhode Island;","institution_ids":["https://openalex.org/I4210089059"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035501167","display_name":"Muna I. Bitar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089059","display_name":"Neurotech (United States)","ror":"https://ror.org/0083rgp58","country_code":"US","type":"company","lineage":["https://openalex.org/I4210089059"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Muna I. Bitar","raw_affiliation_strings":["Neurotech Pharmaceuticals, Cumberland, Rhode Island;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurotech Pharmaceuticals, Cumberland, Rhode Island;","institution_ids":["https://openalex.org/I4210089059"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5141200417","display_name":"Joanna Yankey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267304","display_name":"Veristat, LLC (United States)","ror":"https://ror.org/023qnpq80","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267304"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanna Yankey","raw_affiliation_strings":["Veristat, LLC, Southborough, Massachusetts;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veristat, LLC, Southborough, Massachusetts;","institution_ids":["https://openalex.org/I4405267304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000916453","display_name":"Lydia Sauer","orcid":"https://orcid.org/0000-0002-5223-9406","observed_orcids":["https://orcid.org/0000-0002-5223-9406"]},"institutions":[{"id":"https://openalex.org/I4210098540","display_name":"Associated Retinal Consultants","ror":"https://ror.org/00envj504","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098540"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lydia Sauer","raw_affiliation_strings":["Associated Retinal Consultants, Royal Oak, Michigan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Associated Retinal Consultants, Royal Oak, Michigan;","institution_ids":["https://openalex.org/I4210098540"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090802305","display_name":"Emily Y. Chew","orcid":"https://orcid.org/0000-0003-0999-9802","observed_orcids":["https://orcid.org/0000-0003-0999-9802"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210139686","display_name":"National Eye Institute","ror":"https://ror.org/03wkg3b53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210139686"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Y. Chew","raw_affiliation_strings":["Division of Epidemiology and Clinical Applications, National Eye Institute/National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Epidemiology and Clinical Applications, National Eye Institute/National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210139686"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109251604","display_name":"Thomas M. Aaberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089059","display_name":"Neurotech (United States)","ror":"https://ror.org/0083rgp58","country_code":"US","type":"company","lineage":["https://openalex.org/I4210089059"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas M. Aaberg","raw_affiliation_strings":["Foundation for Vision Research, Grand Rapids, Michigan;","Neurotech Pharmaceuticals, Cumberland, Rhode Island;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation for Vision Research, Grand Rapids, Michigan;","institution_ids":[]},{"raw_affiliation_string":"Neurotech Pharmaceuticals, Cumberland, Rhode Island;","institution_ids":["https://openalex.org/I4210089059"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.8975681,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10691","display_name":"Retinal Development and Disorders","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/macular-telangiectasia-type-2","display_name":"macular telangiectasia type 2","score":0.9980000257492065},{"id":"https://openalex.org/keywords/reading-speed","display_name":"reading speed","score":0.9860000014305115},{"id":"https://openalex.org/keywords/best-corrected-visual-acuity","display_name":"best-corrected visual acuity","score":0.9860000014305115},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.4620000123977661},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.5249999761581421}],"concepts":[{"id":"https://openalex.org/C2778075232","wikidata":"https://www.wikidata.org/wiki/Q6725785","display_name":"Macular telangiectasia","level":4,"score":0.8187999725341797},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7745000123977661},{"id":"https://openalex.org/C2777970837","wikidata":"https://www.wikidata.org/wiki/Q569389","display_name":"Words per minute","level":3,"score":0.7396000027656555},{"id":"https://openalex.org/C554936623","wikidata":"https://www.wikidata.org/wiki/Q199657","display_name":"Reading (process)","level":2,"score":0.6466000080108643},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6277999877929688},{"id":"https://openalex.org/C119767625","wikidata":"https://www.wikidata.org/wiki/Q618211","display_name":"Optometry","level":1,"score":0.5496000051498413},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.5066999793052673},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.474700003862381},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4239000082015991},{"id":"https://openalex.org/C102959455","wikidata":"https://www.wikidata.org/wiki/Q7313954","display_name":"Repeated measures design","level":2,"score":0.3937000036239624},{"id":"https://openalex.org/C548259974","wikidata":"https://www.wikidata.org/wiki/Q569965","display_name":"Audiology","level":1,"score":0.3901999890804291},{"id":"https://openalex.org/C3019051423","wikidata":"https://www.wikidata.org/wiki/Q199657","display_name":"Reading rate","level":4,"score":0.36640000343322754},{"id":"https://openalex.org/C2776148792","wikidata":"https://www.wikidata.org/wiki/Q3041498","display_name":"Eye disease","level":2,"score":0.33469998836517334},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.3160000145435333},{"id":"https://openalex.org/C2780623050","wikidata":"https://www.wikidata.org/wiki/Q837188","display_name":"Ophthalmoscopy","level":3,"score":0.30709999799728394},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.3037000000476837},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.2939000129699707},{"id":"https://openalex.org/C119340705","wikidata":"https://www.wikidata.org/wiki/Q1628597","display_name":"Analysis of covariance","level":2,"score":0.287200003862381},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.2581000030040741}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1097/iae.0000000000005045","doi":"https://doi.org/10.1097/iae.0000000000005045","is_oa":true,"landing_page_url":"https://doi.org/10.1097/iae.0000000000005045","pdf_url":null,"source":{"id":"https://openalex.org/S19572933","display_name":"Retina","issn_l":"0275-004X","issn":["0275-004X","1539-2864"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina","raw_type":"journal-article"},{"id":"pmid:42961160","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42961160","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina (Philadelphia, Pa.)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1097/iae.0000000000005045","doi":"https://doi.org/10.1097/iae.0000000000005045","is_oa":true,"landing_page_url":"https://doi.org/10.1097/iae.0000000000005045","pdf_url":null,"source":{"id":"https://openalex.org/S19572933","display_name":"Retina","issn_l":"0275-004X","issn":["0275-004X","1539-2864"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7169753690","https://openalex.org/W2052188656","https://openalex.org/W2917250575","https://openalex.org/W2974428405","https://openalex.org/W3009495867","https://openalex.org/W1487328877","https://openalex.org/W4405910486","https://openalex.org/W3019081745","https://openalex.org/W3124621355","https://openalex.org/W2040296016"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"evaluate":[2],"the":[3,14,61,96,126],"relationship":[4],"between":[5,78],"best-corrected":[6],"visual":[7],"acuity":[8],"(BCVA)":[9],"and":[10,32,66,81,214,228,231],"reading":[11,36,52,82,102,127,150,202,217],"speed":[12,37,53,83,128,151,203,218],"in":[13,45,199,240],"sham-treated":[15,112],"cohorts":[16],"from":[17],"two":[18],"Phase":[19],"3":[20],"clinical":[21,215],"trials":[22],"of":[23,92,98,124,142,153],"revakinagene":[24],"taroretcel-lwey":[25],"for":[26,105,118,165,224],"macular":[27],"telangiectasia":[28],"type":[29],"2":[30],"(MacTel)":[31],"to":[33,174],"determine":[34],"whether":[35],"captures":[38],"functional":[39,196,237],"decline":[40,84,152,205],"not":[41],"reflected":[42],"by":[43,130],"changes":[44],"BCVA.":[46],"METHODS:":[47],"This":[48],"secondary":[49],"analysis":[50],"evaluated":[51],"(words":[54],"per":[55,58],"minute":[56],"[wpm]":[57],"eye":[59,99],"using":[60,87],"International":[62],"Reading":[63],"Speed":[64],"Test)":[65],"BCVA":[67,79,140,191,208],"(Early":[68],"Treatment":[69],"Diabetic":[70],"Retinopathy":[71],"Study":[72],"letters)":[73,144],"over":[74,156],"24":[75,157],"months.":[76],"Associations":[77],"loss":[80,123,198,239],"were":[85,172],"examined":[86],"multiple":[88],"linear":[89],"regression.":[90],"Analysis":[91],"covariance":[93],"(ANCOVA)":[94],"assessed":[95],"effect":[97],"laterality":[100],"on":[101],"speed,":[103],"controlling":[104,164],"baseline":[106,166],"factors.":[107],"RESULTS:":[108],"Of":[109],"111":[110],"enrolled":[111],"eyes,":[113],"104":[114],"had":[115],"complete":[116],"data":[117],"analysis.":[119],"For":[120],"every":[121],"1-letter":[122],"BCVA,":[125],"decreased":[129],"2.1":[131],"wpm":[132,155,178],"(P":[133,159],"<":[134,160],"0.0001).":[135,161],"Sixty-eight":[136],"eyes":[137,171,182],"maintained":[138],"stable":[139],"(change":[141],"<5":[143],"but":[145],"experienced":[146],"a":[147,221],"statistically":[148],"significant":[149],"19.4":[154],"months":[158],"An":[162],"ANCOVA":[163],"factors":[167],"revealed":[168],"that":[169,190],"left":[170],"predicted":[173],"read":[175],"approximately":[176],"18.5":[177],"slower":[179],"than":[180],"right":[181],"at":[183],"Month":[184],"24.":[185],"CONCLUSION:":[186],"These":[187],"findings":[188],"suggest":[189],"may":[192,219,232],"incompletely":[193],"capture":[194],"progressive":[195],"vision":[197,238],"MacTel,":[200],"whereas":[201],"detected":[204],"even":[206],"when":[207],"remained":[209],"stable.":[210],"Given":[211],"its":[212],"sensitivity":[213],"relevance,":[216],"provide":[220],"meaningful":[222],"endpoint":[223],"assessing":[225],"MacTel":[226],"progression":[227],"therapeutic":[229],"efficacy":[230],"also":[233],"help":[234],"clinicians":[235],"quantify":[236],"routine":[241],"practice.":[242]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-31T00:00:00"}